Does Jublia Clear Nails?
Jublia (efinaconazole 10% topical solution) treats toenail fungus (onychomycosis) by inhibiting fungal growth, but it does not fully clear nails in most patients. Clinical trials showed complete cure rates of 15-18% after 48 weeks, with mycological cure (no detectable fungus) in 53-55% of cases.[1][2] Many users see partial improvement, like reduced discoloration or thickness, but full visual clearing is uncommon without ongoing use.
How Effective Is Jublia in Trials?
In two phase 3 trials with 1,170 patients, Jublia applied daily for 48 weeks achieved:
- Complete cure (clear nail + no fungus): 17.8% vs. 3.3% placebo.
- Complete or almost complete nail growth: 40-42%.
- Fungus elimination: 53-56%.[1][3]
Results vary by infection severity; milder cases respond better. Relapse occurs in up to 50% within a year post-treatment.[2]
How Long Does It Take to See Results?
Visible changes start at 4-8 weeks, but full effects require 48 weeks of daily application to the affected nail and 5mm under the edge. Nails grow slowly (1-1.5mm/month), so cosmetic clearing lags behind fungal kill.[1][4] Maintenance dosing may be needed for 6-12 months after.
What Do Real Users Report?
Patient reviews on Drugs.com average 5.9/10, with 44% positive experiences. Some report clearer nails after 6-12 months, but complaints include slow progress, no change (35% negative), and recurrence. Amazon and WebMD echo this: partial clearing common, full success rare.[5][6]
Why Doesn't It Clear Nails for Everyone?
Factors include:
- Deep fungal penetration hard to reach topically.
- Incomplete adherence to 48-week regimen.
- Resistant fungi or reinfection from shoes/socks.
- Co-existing conditions like diabetes slow nail growth.[2][4]
Common Side Effects and Risks
Mild irritation (ingrown nails 2-3%, redness 1-2%) affects 15-20%.[1] Safe for long-term use; no systemic absorption issues. Avoid if allergic to azoles.
Alternatives If Jublia Fails
| Treatment | Cure Rate | Time | Notes |
|-----------|-----------|------|-------|
| Kerydin (tavaborole) | 6-9% complete | 48 weeks | Similar topical, slightly lower efficacy. |
| Lamisil (terbinafine oral) | 38% complete | 12 weeks | Higher success but liver risks; needs monitoring. |
| Laser therapy | 20-60% improvement | 3-7 sessions | Expensive ($500+ per session), variable insurance. |
| Penlac (ciclopirox) | 5-9% complete | 48 weeks | Cheaper generic, least effective. |
Consult a doctor for oral options or debridement.[3][7]
Cost and Availability
$600-750 for 48-week supply (4 bottles); generics unavailable as patent expires ~2028.[8] Covered by most insurance for diagnosed onychomycosis.
[1] FDA Label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203567s000lbl.pdf
[2] J Am Acad Dermatol (2013): https://pubmed.ncbi.nlm.nih.gov/23466201/
[3] Drugs.com: https://www.drugs.com/jublia.html
[4] Mayo Clinic Onychomycosis: https://www.mayoclinic.org/diseases-conditions/nail-fungus/diagnosis-treatment/drc-20353300
[5] Drugs.com Reviews: https://www.drugs.com/comments/efinaconazole-topical/jublia.html
[6] WebMD Reviews: https://reviews.webmd.com/drugs/drugreview-165937-jublia-topical
[7] AAFP Guidelines: https://www.aafp.org/pubs/afp/issues/2013/1201/p762.html
[8] DrugPatentWatch: https://www.drugpatentwatch.com/p/tradename/JUBLIA